
Work Here?
TTP develops new technologies and builds businesses from technical advances, acting as an invention engine in Cambridge. It prototypes innovations across life sciences, deep tech, and health tech, and often spins out successful ventures such as TTP Communications (2G/3G chipsets later sold to Motorola) and Cellular Origins (cell and gene therapy manufacturing, Series A $40M). The approach combines in-house invention and collaborative, employee-owned teams that tackle tough technical problems and move ideas toward markets. Its goal is to turn scientific breakthroughs into scalable products and companies that can grow globally, shaping technology ecosystems.
Industries
Consulting
Industrial & Manufacturing
Biotechnology
Healthcare
Company Size
201-500
Company Stage
N/A
Total Funding
N/A
Headquarters
United Kingdom
Founded
1987
Help us improve and share your feedback! Did you find this helpful?
Flexible Work Hours
Remote Work Options
Paid Vacation
Health Insurance
Dental Insurance
Vision Insurance
Wellness Program
Mental Health Support
Conference Attendance Budget
Professional Development Budget
Family Planning Benefits
Fertility Treatment Support
Stock Options
Company Equity
401(k) Retirement Plan
401(k) Company Match
Phone/Internet Stipend
Home Office Stipend
Hybrid Work Options
Paid Holidays
Paid Sick Leave
Parental Leave
Adoption Assistance
Childcare Support
Elder Care Support
Relocation Assistance
Employee Referral Bonus
Meal Benefits
Pet Insurance
Training Programs
Tuition Reimbursement
Professional Certification Support
Mentorship Program
Gym Membership
Commuter Benefits
Legal Services
Employee Discounts
Company Social Events
The Sat Companion prototype will be showcased at Mobile World Congress 2025 in Barcelona, Spain, on March 3–6. Visit us at the Finland Pavilion, Hall 5, Stand 5J45.MONTREAL, Feb. 26, 2025 /PRNewswire/ - Terrestar Solutions, in collaboration with Bittium, TTP plc and Qualcomm Technologies, Inc., introduces the Sat Companion, a next-gen device that enables direct-to-mobile satellite communications on any smartphone, anywhere. With its easy snap-on feature, patent-pending high-gain antenna and powered by the Qualcomm® 9205S Modem, the Sat Companion ensures seamless connectivity, providing users with uninterrupted SMS, chat, voice, and email services even in the most remote areas. Through Terrestar's leadership and the collaborative efforts of its trusted partners—Bittium, TTP, and Qualcomm Technologies—a new generation of high-performance devices is emerging. Together, these telecom leaders bring critical expertise and groundbreaking innovation to bridge cellular gaps and redefine connectivity, ensuring true and dependable mobile satellite communications across Canada and around the world
SAN FRANCISCO, Calif., Oct. 15, 2024 (SEND2PRESS NEWSWIRE) — Neurotech Reports announced that executives from several emerging neurotechnology startups will present for the first time at the 2024 Neurotech Leaders Forum in San Francisco, November 6-7. Among the new presenters are Paxos Medical, a firm that has developed a novel neuromodulation therapy for non-obstructive urinary retention.Image caption: Axonics CEO Ray Cohen will keynote the 24th Annual Neurotech Leaders Forum.Also presenting for the first time will be Katya Sverdlov, CEO and co-founder of JelikaLite, a clinical stage medtech company focused on the treatment of autism. Another new presenter is Emile Radyte, CEO of Samphire Neuroscience in the U.K., which has developed a wearable neuromodulation device for treatment of PMS and menstrual pain.Other entrepreneur presenters at this year’s conference include Emily Mirro, President of SynchNeuro Inc., Andy Gotshalk, CEO, Neurologic Solutions, Luca Ravagnan, CEO of Italian firm WISE srl, Kial Gramley of BackStop Neural, and Imanuel Lerman, CEO, InflammaSense, Inc.Raymond Cohen, CEO of Axonics Inc., will keynote the 24th annual event—the most established in the industry. Mr. Cohen has served as CEO and member of the board of directors of Axonics since co-founding the company in October 2013
Exyte acquires TTP Group to accelerate growth of Biopharma and Life Sciences business.
Exyte acquires TTP Group to accelerate growth of Biopharma and Life Sciences business.
Cellular Origins, a TTP Company, appoints Peter Crossley as Chief Operating Officer.
Find jobs on Simplify and start your career today
Industries
Consulting
Industrial & Manufacturing
Biotechnology
Healthcare
Company Size
201-500
Company Stage
N/A
Total Funding
N/A
Headquarters
United Kingdom
Founded
1987
Find jobs on Simplify and start your career today